Head Prof. Ričardas Rotomskis, Ph.D.
Tel.: +370 5 219 0908;
Fax: +370 5 272 0164;
Email. ricardas.rotomskisnvi.lt
Multilayered upconverting nanoparticles as theranostic platform for in vivo imaging and targeted drug delivery
Our group seeks to improve cancer diagnostics and treatment through high-quality research dedicated to biomedical applicability of new type, upconverting nanoparticles (UCNPs). Multifunctional UCNPs being activatable with near infrared radiation will realize the idea/conception of integrating diagnostic imaging and cancer therapy into a single theranostic platform. Among different systems, the UCNPs represent the most versatile currently available light probes. Due to its special chemical-physical properties UCNPs can be applied in many fields such as bioimaging and drug delivery. UCNPs demonstrates many useful features such as narrow emission bands, large anti-Stokes shift, resistance to photobleaching, high chemical and physical stability, low chemical toxicity and long luminescence lifetimes. Upon the doping of different elements such as Gd and Sm into UCNPs structures, the prepared nanoparticles can also be endowed with more promising functions for multimodality imaging by the combination of fluorescent imaging with other imaging techniques including computed tomography (CT), magnetic resonance imaging (MRI) and positron emission tomography (PET).
Spatial,optical and magnetical properties of UCNPs
Confocal imaging of accumulation of nanoparticles in cells
Cellular internalization of dNPs and dNPs-Ce6. Confocal fluorescence microscopy images of MDA-MB-231 and MCF-7 cells after 1, 3, 6, and 24 h of incubation with dNPs and after 24 h of incubation with dNPs-Ce6 complex. UC signal (λex = 980 nm) is represented by the red color. Cell nuclei were stained with Hoechst (blue) (λex = 404 nm) and filamentous actin was stained with Phalloidin-Alexa 488 (green) (λex = 488 nm). Representative cell images are shown in a wide-field and 3× zoom view. Scale bars in all images correspond to 20 μm (Skripka et al., 2018).
Characterisation of nanoparticles: DLS and ζ potential measurements
Hydrodinamic size distribution of core-only and core-shell upconverting nanoparticles and their zeta potential in the cell culture medium (Baziulyte-Paulaviciene et al., 2017)
Recent publications:
Projects:
Collaboration:
Santariskių str. 1, LT-08660, Vilnius
Company code: 111959420
Account no: LT85 7044 0600 0616 2336
SEB Bank AB, SWIFT CBVI LT 2X
Tel. +370 5 2786700
E-mail administracijanvi.lt
We use Google repatcha to identify if you are not a robot, which helps us to avoid spam.
In order to make this enquiry form active, you should tick "accept performance cookies"
You can choose not to allow some types of cookies to be set according to your privacy preferences.
Functional Cookies (necessary)These cookies are essential for the website to function and cannot be switched off in our systems. They are usually only set in response to actions made by you, which amount to a request for services, such as establishing a session or setting your privacy preferences. These cookies do not store any personally identifiable information and they expire as soon as you leave the website. |
|
Performance CookiesThese cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. We use Google Analytics for this purpose. The data collected is not shared with any other party. The information we get through the use of these cookies is anonymised and we make no attempt to identify you, or influence your experience of the site while you are visiting it. If you do not allow these cookies, we will not be able to include your visit in our statistics. |
|
Advertising cookiesThese cookies are used by us and third parties to serve ads that are relevant to your interests. We use cookies to collect data about your online activity and identify your interests so that we can provide advertising that is most relevant to you. You can opt out of receiving interest-based advertising by leaving the checkbox above empty. |